Patent issue settled and new 5 year agreement with BSP

MKTUPDTE
Wed, Jul 02 2025 08:30 am

2 July 2025

Patent issue settled and new 5 year agreement with BSP

On 14 October 2024, based on the information we had on hand at the time, we advised the market about a breach of contract by Bluestone Pharma GmbH (BSP) and Lactosan GmbH & Co. KG (Lactosan).

Since then, BSP and BLIS Technologies Limited (BLIS) have been progressing communications in relation to the patent applications filed by BSP. BLIS and BSP are pleased to report that these negotiations have concluded, with BSP and BLIS agreeing that the patent applications will be jointly owned. This is a positive step forward for both BLIS, BSP and Lactosan, and provides certainty of access for BLIS and its licensees to this market leading technology developed, and contributed to, by BLIS, BSP and Lactosan. As part of this arrangement, BLIS, BSP and Lactosan have released each other of all claims and causes of action arising from the publication of the patent applications.

BLIS would like to thank both BSP and Lactosan for their willingness to engage positively on this matter and the transparent and ethical manner in which both parties have conducted themselves during the course of the negotiations.

BLIS and BSP are also pleased to announce they have renegotiated a five year extension to their existing supply agreement that was scheduled to expire this month.

Ends

For further information, please contact:

Scott Johnson
CEO
+64 21 488 831

About BLIS Technologies Ltd

Delivering proven health benefits through evidence-based, advanced probiotics
BLIS Technologies is an NZX-listed manufacturer of advanced probiotic strains that go beyond the gut. Combining innovation with evidence-based research and the highest quality production controls enables the delivery of probiotic solutions for specific health targets including throat health, halitosis (bad breath), immune support, teeth and gum health and skin health. BLIS® products are sold throughout New Zealand and in Asia, Europe and the USA. More information about BLIS Technologies Ltd can be found at www.blis.co.nz.

Website: www.blis.co.nz
Instagram: @blisprobiotics #blisk12 #blism18 #blisq24
Facebook: @BLISProbiotics


Announcement PDF


Markets News

NZ sharemarket gains as Fletcher hands over NZICC
Markets

NZ sharemarket gains as Fletcher hands over NZICC

Market leader Fisher & Paykel Healthcare was up 25c. 

Graham Skellern 04 Nov 2025
Markets

Being AI’s bold plan: No business, still listed

From wannabe Google challenger to now selling off its last business to escape debt.

Being AI’s bold plan: No business, still listed
Finance

Westpac NZ eyes improved full-year 2026 profit on GDP gains

Looks to grow at pace of economy, invests in business. 

Andy Macdonald 04 Nov 2025
Westpac NZ eyes improved full-year 2026 profit on GDP gains